Categories: News

MediGO Partners with The Alliance to Support Emerging Trends in Organ Donation and Transplantation

“The Alliance”

Leadership and Engaged Learning in Organ Donation and Transplantation

BALTIMORE, Feb. 09, 2022 (GLOBE NEWSWIRE) — MediGO, a first-of-its-kind logistics platform that enables real-time management of time-sensitive medical resources on a centralized communication channel, recently partnered with the Organ Donation and Transplantation Alliance (“The Alliance”) to support healthcare professionals in the field of donation and transplantation that are committed to learning about new innovations and effective practices.  

The Alliance delivers relevant, targeted, and scalable learning solutions for the organ donation and transplantation community of practice – including organ procurement organizations, transplant centers and programs, and hospitals where donations occur. By convening members across the community of practice, it is a platform to identify emerging concepts and innovative practices, and cascading resources and educational programs of transformational quality and value. The Alliance is not a membership organization, but partners with leading organizations across the continuum to advance a shared mission to save and heal lives through organ donation and transplantation.

David Castiglioni, CCO, MediGO, says, “We are incredibly excited about MediGO’s partnership with The Alliance. The resources they provide to the transplant community impact patients’ lives. We look forward to sharing our innovations to further their mission.”

MediGO will be supporting many new collaborative initiatives and learning programs throughout the year with The Alliance. 

About MediGO
MediGO, is a first-of-its-kind logistics platform that enables real-time management of time-sensitive medical resources on a centralized communication channel. Powered by proprietary algorithms and machine learning, MediGO provides the most accurate tracking and estimated times of arrival in the industry. With newfound supply chain transparency, care teams can proactively unify stakeholders, coordinate resources, and minimize waste – to improve quality and deliver confidence. For more information about MediGO, a JSP Ventures company, visit https://www.gomedigo.io/.

About JSP Ventures
JSP Ventures is a propeller of visionary brands. Through long-term capital investments and strategic guidance, JSP Ventures is fueling the growth of industries including logistics and supply chain, medical and healthcare, unmanned aircraft systems and more. Guided by a mission to better communities and improve lives, JSP Ventures has invested over $20 million of personally endowed capital to create lasting, positive change. Learn more at http://www.jspventures.com.

Media Contact:
Janet Kaplan
MediGO Director of Marketing
240.505.5151
jkaplan@gomedigo.io

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/19d0ae16-a44f-47f0-bd3b-a14fe5eb4aa9

Staff

Recent Posts

RPI Consultants Presents Annual Scholarship to Healthcare Technology Professional

BALTIMORE, Feb. 5, 2026 /PRNewswire/ -- RPI Consultants, a leading ERP implementation, optimization, and software firm…

2 hours ago

BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration

LONDON, Feb. 5, 2026 /PRNewswire/ -- BioPhorum, the pharmaceutical industry's most trusted collaborative network for…

2 hours ago

BC Platforms partners with OmicsBank to expand access to large-scale real-world and multi-omics data from India and the UAE

Patient catchment now includes 187 million+ patient lives, enables advanced analytics and AI modeling for…

2 hours ago

Electron Microscopy Market to Reach $10.3 billion, Globally, by 2034 at 8.1% CAGR: Allied Market Research

The electron microscopy market is driven by rapid advancements in nanotechnology, increase in demand for…

2 hours ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery

VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / BioNxt Solutions Inc. ("BioNxt" or…

2 hours ago

Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism

In the study, [68Ga]Ga-Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity…

5 hours ago